Literature DB >> 1528954

Metabolic activation of carcinogens.

F P Guengerich1.   

Abstract

Most chemical carcinogens are not active in themselves but require bioactivation to electrophiles that bind covalently to DNA and often act by producing mutations. In recent years it has been realized that mutations can be important at many stages of carcinogenesis. A variety of different enzymes are involved in bioactivation reactions, which include oxidation, reduction, thiol conjugation, acetyl transfer, sulfur transfer, methyl transfer, glucuronosyl transfer, and epoxide hydrolysis. These processes often occur in concert with a single carcinogen. Humans vary considerably in activities of these enzymes and this variation may contribute to differences in risk.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1528954     DOI: 10.1016/0163-7258(92)90050-a

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  36 in total

Review 1.  Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition.

Authors:  Stephanie M Tortorella; Simon G Royce; Paul V Licciardi; Tom C Karagiannis
Journal:  Antioxid Redox Signal       Date:  2014-12-19       Impact factor: 8.401

2.  Initial oxidative and subsequent conjugative metabolites produced during the metabolism of phenanthrene by fungi.

Authors:  R P Casillas; S A Crow; T M Heinze; J Deck; C E Cerniglia
Journal:  J Ind Microbiol       Date:  1996-04

3.  Enantiomeric Composition of the trans-Dihydrodiols Produced from Phenanthrene by Fungi.

Authors:  J B Sutherland; P P Fu; S K Yang; L S Von Tungeln; R P Casillas; S A Crow; C E Cerniglia
Journal:  Appl Environ Microbiol       Date:  1993-07       Impact factor: 4.792

Review 4.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism.

Authors:  M Pirmohamed; S Madden; B K Park
Journal:  Clin Pharmacokinet       Date:  1996-09       Impact factor: 6.447

5.  Cytochrome P450 isoform selectivity in human hepatic theobromine metabolism.

Authors:  S Gates; J O Miners
Journal:  Br J Clin Pharmacol       Date:  1999-03       Impact factor: 4.335

Review 6.  Hepatic neoplasia: reflections and ruminations.

Authors:  K Aterman
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  Characterization of Phase I biotransformation enzymes in coho salmon (Oncorhynchus kisutch).

Authors:  Aline Y O Matsuo; Evan P Gallagher; Mary Trute; Patricia L Stapleton; Ramon Levado; Daniel Schlenk
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2007-08-14       Impact factor: 3.228

8.  Cytochrome P450 expression in oesophageal cancer.

Authors:  G I Murray; D Shaw; R J Weaver; J A McKay; S W Ewen; W T Melvin; M D Burke
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

9.  CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study.

Authors:  Carmen San Jose; Agustin Cabanillas; Julio Benitez; Juan Antonio Carrillo; Mercedes Jimenez; Guillermo Gervasini
Journal:  BMC Cancer       Date:  2010-08-30       Impact factor: 4.430

10.  Biotransformation enzyme activities in the olfactory organ of rainbow trout (Oncorhynchus mykiss). Immunocytochemical localization of cytochrome P4501A1 and its induction by β-naphthoflavone.

Authors:  G Monod; D Saucier; E Perdu-Durand; M Diallo; J P Cravedi; L Astic
Journal:  Fish Physiol Biochem       Date:  1994-12       Impact factor: 2.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.